Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNF-blocking therapy and cardiac function in active rheumatoid arthritis
NL-OMON44306Active, not recruiting
- Sponsor
- Jan van Breemen Institute
- Start
- Dec 2014
- Countries
- 1
01
Overview
Open-label, single-arm trial in rheumatoid arthritis (RA), sponsored by Jan van Breemen Institute. Primary endpoint: Diastolic left ventricular dysfunction. Started Dec 2014; status: active, not recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON44306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44306.